Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2161 to 2175 of 9019 results

  1. High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus in high risk or immunocompromised patients

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Transarterial Chemoembolisation for inoperable hepatocellular carcinoma

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. The Extraperitoneal approach to left sided colorectal resections ( EXPERTS) Procedure

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Percutaneous cryotherapy (PCT) for the therapy of primary lung cancer or metastatic lung cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Percutaneous Laser (Photo) Ablation of Liver Tumours

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  8. Magtrace/Sentimag MT599 (MIB263)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  9. Archimedes for biopsy of suspected lung cancer

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  10. Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  11. Gemcitabine intravesical delivery system for treating recurrent high-risk papillary non-muscle-invasive bladder after BCG [ID6657]

    Awaiting development Reference number: GID-TA11872 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver

    In development Reference number: GID-IPG10448 Expected publication date:  15 October 2026

    Interventional procedures guidance
    In development

  13. Dostarlimab for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency when systemic treatment is suitable [ID6660]

    Awaiting development Reference number: GID-TA11870 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Gemcitabine intravesical delivery system for treating high-risk non-muscle-invasive bladder cancer untreated with BCG [ID6658]

    Awaiting development Reference number: GID-TA11868 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Inavolisib with fulvestrant for treating recurrent hormone receptor-positive HER2-negative PIK3CA-mutated locally advanced or metastatic breast cancer after a CDK 4-6 inhibitor [ID6650]

    Awaiting development Reference number: GID-TA11862 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development